Shukra Pharmaceuticals Limited approved the preferential issue of 46,43,000 convertible equity warrants to promoters for cash consideration during its Extra Ordinary General Meeting (EOGM) held on July 06, 2026. The approval was secured via a special resolution under Regulation 170(2) of the SEBI (ICDR) Regulations, 2018, enabling the company to raise capital from its promoters.

The meeting was conducted through video conferencing and other audio-visual means in compliance with the Companies Act, 2013, and relevant circulars issued by the Ministry of Corporate Affairs and the Securities and Exchange Board of India (SEBI). Mr. Dakshesh Shah, Managing Director, chaired the meeting, which commenced at 12:00 p.m. and concluded at 12:25 p.m. (IST).

Voting and Proceedings

The requisite quorum was present for the meeting. The company appointed Mrs. Rupal Patel, a Practicing Company Secretary, as the Scrutinizer to oversee the remote e-voting process and the e-voting conducted during the EOGM. Remote e-voting was open from July 03, 2026, at 09:00 a.m. to July 05, 2026, at 05:00 p.m., facilitated by Purva Sharegistry (India) Private Limited.

Resolution Details

The sole item on the agenda was the special business regarding the preferential allotment. The details of the resolution passed are as follows:

No queries were raised by the shareholders during the meeting. The results of the voting will be announced within 48 hours of the conclusion of the meeting and will be displayed on the company's website and the stock exchanges.

Shukra Pharmaceuticals appointed Shivkant Dhakad as Company Secretary and Compliance Officer effective June 15, 2026. The Board of Directors approved the appointment during its meeting held on June 15, 2026. Dhakad brings 1.5 years of experience as an Assistant Company Secretary, with expertise in regulatory compliance, corporate filings, and board meeting coordination.

Concurrently, the Board accepted the resignation of Ms. Arpita Kabra from the post of Company Secretary and Compliance Officer, effective June 15, 2026. Kabra cited personal reasons and other professional commitments for her departure. The transition complies with Regulation 30 and Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with the SEBI Master Circular dated November 11, 2024.

Key Personnel Changes

The following table summarizes the changes in the company's secretarial and compliance leadership:

Dhakad, a member of the Institute of Company Secretaries of India (Membership No. A80894), confirmed his consent to act as Company Secretary and Compliance Officer pursuant to Section 203 of the Companies Act, 2013. He affirmed that he possesses the requisite qualifications and is not disqualified from holding the position under any applicable law.